Cape Verde vs Solomon Islands: Previously treated cases tested for RR-/MDR-TB
Cape Verde
20.0%
in 2024
Solomon Islands
9.1%
in 2024
Cape Verde rank
165th
Solomon Islands rank
167th
Previously treated cases tested for RR-/MDR-TB over time
- Cape Verde
- Solomon Islands
How they compare
Cape Verde currently reports 20.0% against 9.1% in Solomon Islands, a difference of 10.9%.
That makes Cape Verde's figure about 2.2 times Solomon Islands's.
The two have swapped places 5 times across 14 shared years of data; in 2009 it was Solomon Islands ahead.
Cape Verde ranks 165th and Solomon Islands ranks 167th of 180 countries.
Across the 3 decades both report, Cape Verde averaged higher in 1 and Solomon Islands in 2.
Head to head by decade
| Decade | Cape Verde | Solomon Islands | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 100.0% | 100.0% | Solomon Islands |
| 2010s | 19.5% | 33.2% | 13.7% | Solomon Islands |
| 2020s | 59.6% | 45.2% | 14.4% | Cape Verde |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Cape Verde or Solomon Islands?
- Cape Verde, at 20.0% against 9.1% in Solomon Islands as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Cape Verde and Solomon Islands?
- 10.9%, with Cape Verde ahead.
- How many years of comparable data are there for Cape Verde and Solomon Islands?
- 14 years are reported by both, from 2009 to 2024.
- How do Cape Verde and Solomon Islands rank globally for previously treated cases tested for rr-/mdr-tb?
- Cape Verde ranks 165th and Solomon Islands ranks 167th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.